TRADERSPRO PRESENTS Retire In 18 Months With $2.4 Million?

37 year old trader uses this “unconventional” strategy to turn $10K into $2.4 million in only 18 months. Another trader turned $5K into $15 million and still another turned $30K into $80 million. Click here to discover their millionaire maker strategy. - 

Starting Soon - Please Join Us 

Biopharmaceuticals
Biotech
China
Daily Rundown
Donald Trump
Economic Trends
Economy
Pharmaceuticals
Social Media
Stock Picks
Tech Industry
US Economy

Biogen Shares Jump After FDA Gives Priority Review To Its Alzheimer’s Drug

Plus, President Trump issued an executive order banning TikTok and WeChat, July job gains came in just under 1.8 million, and coronavirus relief bill talks have stalled.

Read More
Biopharmaceuticals
Penny Stocks
TradersPro Penny Stocks

Soleno Therapeutics, Inc. (SLNO)

Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.   The stocks are pausing a trend either up or down, with a new bar over the prior day open or close.  These are high reward to risk stocks with the […]

Read More
Biomedical
Biotech
One Hot Stock

CohBar, Inc. (CWBR) – Buy Price: $2.00 or better

Buy Price: $2.00 or better Sell Price: TradersPro Sell Signal CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of diseases associated with aging and metabolic dysfunction. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, type 2 diabetes […]

Read More
Agriculture
Fertilizer
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Materials
Technical Analysis
Value Investing

Is MOS ready to break out of its two-year downward trend?

There is a pretty significant difference in the way different investors perceive a stock in a long-term downward trend. For growth oriented-investors, the longer the downward trend, the less attractive the stock is, simply because the expectation is that the longer, bearish trend will outlast any near-term, bullish sentiment or momentum the stock may see. […]

Read More
Market Forcast

Goldman Sachs Just Warned We Could Be Stuck In A “Fat & Flat” Market Range For A While – Here’s Why

The market will be ‘fat and flat’ in the near-term according to one Goldman analyst, but this is how investors can play it.

Read More
Beauty and Cosmetics
Retailers
Specialty Retailers
Stock Picks

This Year’s Back-To-School Season Will Be Like No Other & One Analyst Says That Makes These 2 Stocks A Buy

The coronavirus has thrown a wrench in this year’s back-to-school season, but these 2 stocks could still see a boost as students prep for a new school year.

Read More
Gold
Gold Stocks
Mining
Stock Picks

2 Gold Stocks To Buy To Ride The Precious Metal’s Surge To All-Time Highs

Experts say these 2 gold stocks may be the best way to take advantage of the metal’s climb higher.

Read More
Biopharmaceuticals
One Hot Stock

MyoKardia, Inc. (MYOK) – Buy Price: $105 or better

Buy Price: $105 or better Sell Price: TradersPro Sell Signal MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is mavacamten, an orally administered small molecule, which is in Phase III clinical trial that is designed to […]

Read More
Biopharmaceuticals
Biotech
Daily Rundown
Donald Trump
Earnings Reports
Economy
Gaming
Health
Marijuana
Pharmaceuticals
Stock Picks
US Economy

Nintendo Just Reported Operating Profits Surged 428% Amid The Coronavirus Pandemic

Plus, weekly jobless claims hit their lowest level in the pandemic era but still came in above 1 million, White House and congressional Democratic negotiators have a self-imposed deadline of Friday to come to agreement on a relief package, and Bausch Health is spinning off is eye care business.

Read More

There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Companys software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.

FREE TRADING WEBINAR - TRADERSPRO PRESENTS: Starting With Only $10,000 Retire With $2.4 Million? Click Here Now

Join Us Now
X